Fate Therapeutics FATE 深 沪
已收盘 10-31 16:00:00 美东时间
1.35
+0.060
+4.65%
华盛通- 最 高1.505
- 今 开1.40
- 成交量 154.85万股
- 最 低 1.34
- 昨 收 1.29
- 总市值 1.55亿
- 52周最高 3.50
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.6611
- 委 比 70.70%
- 总股本 1.15亿
- 历史最高 121.16
- 量 比 0.46
- 振 幅 12.79%
- 历史最低 0.6611
- 每 手 1
- 风险率 0.49%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 买入！Fermi、Neptune获多家大行首予评级；伯克希尔哈撒韦罕见地获得“卖出”评级；摩根大通上调苹果目标价升至290美元
今日重点评级关注：Guggenheim：上调Neumora Therapeutics评级至"买入"，目标价14美元；韦德布什：上调Fate Therapeutics评级至"跑赢大市"，目标价从5美元升至7美元
10-28 10:08
Needham Reiterates Hold on Fate Therapeuticsto Hold
Needham analyst Gil Blum reiterates Fate Therapeutics (NASDAQ:FATE) from Hold to Hold.
10-27 17:40
Fate Therapeutics Presents New Clinical Data at ACR Convergence 2025 Demonstrating Immune Remodeling and Durable Responses in Patients with Systemic Lupus Erythematosus Treated with FT819 Off-the-Shelf CAR T-Cell Therapy
Fate Therapeutics announced positive data from a Phase 1 trial of FT819, an off-the-shelf CAR T-cell therapy for moderate-to-severe systemic lupus erythematosus (SLE). The trial involved 10 patients treated with FT819, showing significant reductions in disease activity and favorable safety profiles, with no dose-limiting toxicities. Patients with lupus nephritis achieved complete kidney responses, and extrarenal lupus patients experienced marked ...
10-26 15:30
Fate Therapeutics appoints new CFO to support autoimmune program expansion
Fate Therapeutics (NASDAQ:FATE) has appointed Kamal Adawi as chief financial officer, effective October 20, 2025. Adawi brings over 20 years of financial leadership experience in life sciences, includ...
10-14 20:15
Fate Therapeutics Expands Leadership Team with Appointment of Kamal Adawi as Chief Financial Officer
Fate Therapeutics任命Kamal Adawi为首席财务官，Adawi拥有20多年的生命科学行业财务领导经验，尤其在自身免疫性疾病领域。Adawi曾在多家生物技术公司担任CFO，并带领Exagen成功进行IPO。他的加入将为Fate Therapeutics带来在财务战略、资本形成方面的丰富经验，支持公司临床项目的推进，包括FT819在系统性红斑狼疮（SLE）中的注册试验。Fate Therapeutics利用其专有的诱导多能干细胞(iPSC)平台，致力于开发创新的“即用型”细胞免疫疗法，以矫正治疗方案。
10-14 12:00
申城秋韵｜全球最大规模，超12万人次打卡！“二次元”在这里“买买买”
等候入场的观众，主办方提供 10月2日上午7时30分，距离入场时间还有近两小时，手办模型爱好者李立到达上海新国际博览中心的普通票观众通道时，早已有人守候。这时...
10-03 16:45
吸引超2000名展商、12万人次打卡，B站举办全球最大规模手办模型展
（来源：三文娱） 10月2日至10月3日，由B站独家承办的手办模型展 Wonder Festival 2025（以下简称“WF2025”）在上海新国际博览中心...
10-03 11:33
美股牛股 | ANAB大涨超31%！宣布重大业务重组计划；Wolfspeed再涨超29%，宣布脱离破产保护
ANAB大涨超31%！宣布重大业务重组计划；Wolfspeed再涨超29%，宣布脱离破产保护；MFH昨日涨近26%，美国SEC释放监管利好信号>>
10-01 20:34
硬核实力再获认可！广电运通在算法与数据应用领域取得多项突破
核心导读 近日，广电运通各成员企业在前沿技术创新、国内数据应用领域与市场拓展持续取得重大突破，始终坚持用硬核实力诠释行业自信，以实际行动彰显企业使命。像素数据...
09-01 18:04
Fate Therapeutics to Present at Upcoming Investor Conferences
Fate Therapeutics, a clinical-stage biopharmaceutical company developing iPSC-derived cellular immunotherapies, announced its participation in two upcoming investor conferences: the 2025 Wells Fargo Healthcare Conference on September 3, 2025, in Boston, MA, and the Cantor Global Healthcare Conference 2025 on September 4, 2025, in New York, NY. The Company will host one-on-one meetings and a fireside chat during these events. Live and archived web...
08-25 12:00
